British fund giant Baillie Gifford launches tokenization pilot project on Ethereum

2025/06/21 19:30

PANews reported on June 21 that Tom Wan, head of data at Entropy Advisors, published an article on the X platform, revealing that Baillie Gifford, one of the largest mutual funds in the UK with assets under management of 197 billion pounds, announced that it has chosen Ethereum to launch a fully tokenized UCITS fund. The regulated Strategic Bond Feeder Fund is also a tokenization pilot project of Baillie Gifford.

It is reported that UCITS funds are a special investment tool in the European Union, known as collective investment plans for transferable securities, which specialize in investing in tradable securities. As part of the pilot, Baillie Gifford plans to hold the fund's tokens in a self-custodial wallet. During the pilot, the tokenized fund will be exclusively available to a group of selected whitelisted customers.

Clause de non-responsabilité : les articles republiés sur ce site proviennent de plateformes publiques et sont fournis à titre informatif uniquement. Ils ne reflètent pas nécessairement les opinions de MEXC. Tous les droits restent la propriété des auteurs d'origine. Si vous estimez qu'un contenu porte atteinte aux droits d'un tiers, veuillez contacter service@support.mexc.com pour demander sa suppression. MEXC ne garantit ni l'exactitude, ni l'exhaustivité, ni l'actualité des contenus, et décline toute responsabilité quant aux actions entreprises sur la base des informations fournies. Ces contenus ne constituent pas des conseils financiers, juridiques ou professionnels, et ne doivent pas être interprétés comme une recommandation ou une approbation de la part de MEXC.
Partager des idées

Vous aimerez peut-être aussi

Bio Protocol Raises $6.9M to Advance AI-Powered Decentralized Science

Bio Protocol Raises $6.9M to Advance AI-Powered Decentralized Science

The post Bio Protocol Raises $6.9M to Advance AI-Powered Decentralized Science appeared on BitcoinEthereumNews.com. Decentralized science (DeSci) platform Bio Protocol secured backing from investors including Maelstrom Fund and Animoca Brands to expand its artificial intelligence-native biotech research framework.  Bio Protocol announced Wednesday that it had raised $6.9 million in funding, reflecting growing interest in decentralized approaches to drug discovery that integrate AI, blockchain and community engagement.  Maelstrom founder Arthur Hayes described Bio Protocol as a potential “category-defining launchpad” for scientific research. “If it works, it’s not just a launchpad – it’s the birth of an AI-native research market,” he said. Hayes also highlighted how it opens up research opportunities that communities find appealing, not just what academics find interesting.  Cointelegraph reached out to Maelstrom and Animoca for more information, but did not receive a response by publication.  Source: Bio Protocol Speeding up science using AI and crypto DeSci is a movement that uses blockchain technology, crypto incentives and decentralized governance to change how scientific research is conducted, funded and shared. Bio Protocol said it’s speeding up science by integrating crypto and AI. Its approach compresses the drug discovery pipeline using blockchain-based funding and coordination.  Instead of waiting years for traditional grants to be awarded or pharma partnerships to be formed, researchers can use decentralized AI agents, dubbed “BioAgents” that generate hypotheses, connect to onchain wallets and channel community-raised capital into experiments.  Each step of the process will be recorded onchain, ensuring that contributors will be credited and maintaining an immutable record of research progress.  The protocol also uses crypto-native incentives to keep research moving faster. It uses tokenized intellectual property, staking systems and loyalty rewards to align investors, researchers and community members around shared outcomes.  Related: ‘Science needs an update’: How DeSci can fix junk science and cure baldness Addressing inefficiencies in academic research Simon Dedic, the founder of Moonrock Capital, one of Bio…
Partager
BitcoinEthereumNews2025/09/19 11:05
Partager